Show simple item record

dc.contributor.authorShaikh, Amir Y.
dc.contributor.authorMann, Abhishek
dc.contributor.authorHeist, E. Kevin
dc.contributor.authorTighe, Dennis A.
dc.contributor.authorAurigemma, Gerard P.
dc.contributor.authorMcManus, David D.
dc.date2022-08-11T08:09:24.000
dc.date.accessioned2022-08-23T16:29:18Z
dc.date.available2022-08-23T16:29:18Z
dc.date.issued2012-11-12
dc.date.submitted2013-01-02
dc.identifier.citation<p>Cardiol Rev. 2012 Nov-Dec;20(6):288-96. doi: 10.1097/CRD.0b013e31825dcf9b. <a href="http://dx.doi.org/10.1097/CRD.0b013e31825dcf9b" target="_blank">Link to article on publisher's site</a></p>
dc.identifier.issn1061-5377 (Linking)
dc.identifier.doi10.1097/CRD.0b013e31825dcf9b
dc.identifier.pmid22581123
dc.identifier.urihttp://hdl.handle.net/20.500.14038/37215
dc.description.abstractAtrial fibrillation (AF) and heart failure (HF) frequently occur together, and their coexistence is associated with a poor prognosis. AF and HF share risk factors, but their relationship involves complex hemodynamic, neurohormonal, inflammatory, ultrastructural, and electrophysiologic processes that extend beyond epidemiological associations. The shared mechanisms underlying AF and HF have important implications for the treatment of AF in patients with HF. This article focuses on reviewing contemporary data as it pertains to AF management in patients with HF and provides insight into investigational therapies currently under development.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22581123&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1097/CRD.0b013e31825dcf9b
dc.subjectAtrial Fibrillation
dc.subjectHeart Failure
dc.subjectCardiology
dc.subjectCardiovascular Diseases
dc.titleManagement strategies in atrial fibrillation in patients with heart failure
dc.typeJournal Article
dc.source.journaltitleCardiology in review
dc.source.volume20
dc.source.issue6
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/meyers_pp/630
dc.identifier.contextkey3560235
html.description.abstract<p>Atrial fibrillation (AF) and heart failure (HF) frequently occur together, and their coexistence is associated with a poor prognosis. AF and HF share risk factors, but their relationship involves complex hemodynamic, neurohormonal, inflammatory, ultrastructural, and electrophysiologic processes that extend beyond epidemiological associations. The shared mechanisms underlying AF and HF have important implications for the treatment of AF in patients with HF. This article focuses on reviewing contemporary data as it pertains to AF management in patients with HF and provides insight into investigational therapies currently under development.</p>
dc.identifier.submissionpathmeyers_pp/630
dc.contributor.departmentMeyers Primary Care Institute
dc.contributor.departmentDepartment of Medicine, Division of Cardiovascular Medicine
dc.source.pages288-96


This item appears in the following Collection(s)

Show simple item record